You are viewing the site in preview mode

Skip to main content

Advertisement

Table 2 Outcomes of Antituberculosis and Antiretroviral Treatment

From: Early versus delayed initiation of antiretroviral therapy for Indian HIV-Infected individuals with tuberculosis on antituberculosis treatment

Outcome of ATT at 6 months/completion
Outcome Early ART (n = 88) Delayed ART (n = 62) P value
Successfully treated 93.4% (71/76) 93.1% (54/58) 0.105 (Overall)
Failure 6.6% (5/76) 5.2% (3/58)  
Treatment Modified 1.3% (1/76) 1.7% (1/58)  
Losses during ATT:    
Died 06 (6.8%) 04 (6.4%)  
Lost to Follow Up 06 (6.8%) 00 (0.0%)  
Outcome of ART at 12 months
Outcome Early ART (n = 88) Delayed ART (n = 62) P value
HIV Disease Progression 14 (16%) 19 (31%) 0.045
Clinical Failure 00 (0%) 01 (1.6%) 0.413
Immunological failure 08 (9.1%) 14 (22.6%) 0.033
Virological failure 08 (09.1%) 08 (12.9%) 0.592
Lost to follow up 11 (12.5%) 01 (1.6%)  
  1. ART = Antiretroviral therapy, ATT = Antituberculosis treatment.